Latest Media Releases (Page 2) | Finance News Network

Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Immutep Announces Details for Oral Presentation at ESMO Virtual Plenary Session and Webcast to Discuss Clinical Results (ASX:IMM)

SYDNEY, AUSTRALIA – July 3rd, 2024 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing nove...read more

Sequoia Financial Group - Sale of General Insurance Broking Business (ASX:SEQ)

Sequoia Financial Group Limited (ASX: SEQ) has sold its general insurance broking businesses to WIB Corporate Pty Ltd, a company 100% owned and controlled by Cameron Bott. WIB Corporate has acqui...read more

Santana Minerals - Infill drilling increases RAS Indicated category to 1.45Moz (ASX:SMI)

The Board of Santana Minerals (ASX:SMI, Santana, or the Company) is pleased to advise that ongoing infill drilling has continued to upgrade the down plunge Inferred Resource at the Rise and Shine di...read more

Santana Minerals applies to add New Zealand Stock Exchange Listing (ASX:SMI)

Santana is pleased to advise that it has made an application to obtain a secondary listing on the NZX Main Board Market operated by NZX Limited (NZX) in addition to its primary listing on the Austra...read more

Sequoia Financial Group - Declaration of Unacceptable Circumstances (ASX:SEQ)

The Panel has made a declaration of unacceptable circumstances (Annexure A) in relation to an application dated 15 May 2024 by Sequoia Financial Group Limited (Sequoia) in relation to its affairs (s...read more

Sequoia Financial Group - Change of Registered Office Address (ASX:SEQ)

In accordance with listing rules 3.14, the Company wishes to advise that effective today, the Company’s registered office address has changed to: Suite 7.01, Level 7 1 Castlereagh Street ...read more

Immutep - Webcast slides for new Efti clinical data in 1st line HNSCC (ASX:IMM)

To view the presentation, download the attached PDF.

Immutep - Positive topline results from ph2b in head & neck cancer (ASX:IMM)

Efti in combination with KEYTRUDA® (pembrolizumab) in first line head and neck squamous cell carcinoma (1L HNSCC) led to overall response rates that exceed KEYTRUDA monotherapy a...read more

Etherstack - Reinstatement to Official Quotation (ASX:ESK)

Description The suspension of trading in the securities of Etherstack PLC (‘ESK’) will be lifted immediately following lodgement of its Full Year Statutory Accounts for the perio...read more

Immutep signs agreement for anti-LAG-3 small molecules (ASX:IMM)

SYDNEY, AUSTRALIA – 25 June 2024 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel L...read more

Lithium Universe - Prospectus (ASX:LU7)

To view the presentation, download the attached PDF.

Immutep completes underwritten retail entitlement offer (ASX:IMM)

Immutep Limited ACN 009 237 889 (ASX: IMM) (Immutep or the Company) is pleased to announce the completion of the retail component of its fully underwritten Entitlement Offer (details of which were a...read more

Rural Funds Group - Lease and partial sale of cropping properties (ASX:RFF)

Rural Funds Management Limited (RFM), as responsible entity of Rural Funds Group (RFF), advises it has entered into an agreement for the lease of two cropping properties, Mayneland and Baamba P...read more

IVE Group Reaffirms FY24 Guidance (ASX:IGL)

IVE Group intended updating investors on its FY24 YTD performance at the recent Bell Potter Emerging Leaders Conference, however, due to the passing of the Group’s then Executive Chairman, Geo...read more

Western Yilgarn - Ida Holmes Junction Project expanded by Strategic Farm-in (ASX:WYX)

HIGHLIGHTS Farm-in and Joint Venture agreement with Bellpark Minerals secures WYX the exclusive right to earn into 2 key tenements : - E36/...read more

Viewing: 16 - 30 of 200 Previous | Next